Trial · NCT02465268
Adverse events129
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 129
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | CD4 Count | Blood and lymphatic system disorders | pp65-shLAMP DC With GM-CSF and Td (Arm 1) | 1 | 36 | |
| other | CD4 Count | Blood and lymphatic system disorders | pp65-flLAMP DC With GM-CSF and Td (Arm 2) | 0 | 34 | |
| other | CD4 Count | Blood and lymphatic system disorders | Unpulsed PBMC and Saline (Arm 3) | 0 | 41 | |
| other | Lymphopenia | Blood and lymphatic system disorders | pp65-shLAMP DC With GM-CSF and Td (Arm 1) | 4 | 36 | |
| other | Lymphopenia | Blood and lymphatic system disorders | pp65-flLAMP DC With GM-CSF and Td (Arm 2) | 6 | 34 | |
| other | Lymphopenia | Blood and lymphatic system disorders | Unpulsed PBMC and Saline (Arm 3) | 5 | 41 | |
| other | Neutrophils/granulocytes | Blood and lymphatic system disorders | pp65-shLAMP DC With GM-CSF and Td (Arm 1) | 1 | 36 | |
| other | Neutrophils/granulocytes | Blood and lymphatic system disorders | pp65-flLAMP DC With GM-CSF and Td (Arm 2) | 0 | 34 | |
| other | Neutrophils/granulocytes | Blood and lymphatic system disorders | Unpulsed PBMC and Saline (Arm 3) | 0 | 41 | |
| other | Platelets | Blood and lymphatic system disorders | pp65-shLAMP DC With GM-CSF and Td (Arm 1) | 1 | 36 | |
| other | Platelets | Blood and lymphatic system disorders | pp65-flLAMP DC With GM-CSF and Td (Arm 2) | 2 | 34 | |
| other | Platelets | Blood and lymphatic system disorders | Unpulsed PBMC and Saline (Arm 3) | 2 | 41 | |
| other | Hypertension | Cardiac disorders | pp65-shLAMP DC With GM-CSF and Td (Arm 1) | 2 | 36 | |
| other | Hypertension | Cardiac disorders | pp65-flLAMP DC With GM-CSF and Td (Arm 2) | 0 | 34 | |
| other | Hypertension | Cardiac disorders | Unpulsed PBMC and Saline (Arm 3) | 4 | 41 | |
| other | Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L) | General disorders | pp65-shLAMP DC With GM-CSF and Td (Arm 1) | 0 | 36 | |
| other | Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L) | General disorders | pp65-flLAMP DC With GM-CSF and Td (Arm 2) | 1 | 34 | |
| other | Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L) | General disorders | Unpulsed PBMC and Saline (Arm 3) | 0 | 41 | |
| other | Bruising | Skin and subcutaneous tissue disorders | pp65-shLAMP DC With GM-CSF and Td (Arm 1) | 0 | 36 | |
| other | Bruising | Skin and subcutaneous tissue disorders | pp65-flLAMP DC With GM-CSF and Td (Arm 2) | 0 | 34 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02465268/events